OFIX (STOCKS)
Orthofix Medical Inc. Common Stock (DE)
$10.180000
-0.220000 (-2.12%)
Prev close: $10.400000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Massimo Calafiore
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $414.25M
- Employees
- 1,616
- P/E (TTM)
- -6.79
- P/B (TTM)
- 0.99
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
4
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.39 | $-0.42 | +0.0282 | +6.74% |
|
Mar 2026 (Q1)
|
$-0.13 | $-0.69 | +0.5636 | +81.26% |
|
Dec 2025 (Q4)
|
$-0.06 | $-0.32 | +0.2562 | +81.02% |
|
Sep 2025 (Q3)
|
$-0.57 | $-0.41 | -0.1552 | -37.42% |
Financial Statements
| Revenues | $833.19M |
| Benefits Costs and Expenses | $893.47M |
| Cost Of Revenue | $239.07M |
| Costs And Expenses | $893.47M |
| Gross Profit | $594.12M |
| Operating Expenses | $633.24M |
| Selling, General, and Administrative Expenses | $557.80M |
| Depreciation and Amortization | $52.79M |
| Research and Development | $61.41M |
| Operating Income/Loss | -$39.12M |
| Income/Loss From Continuing Operations After Tax | -$61.72M |
| Income/Loss From Continuing Operations Before Tax | -$60.29M |
| Income Tax Expense/Benefit | $1.44M |
| Income Tax Expense/Benefit, Deferred | $643.00K |
| Interest Income/Expense After Provision For Losses | -$24.16M |
| Interest Income/Expense Operating, Net | -$20.78M |
| Net Income/Loss | -$61.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$61.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$61.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $3.38M |
| Basic Earnings Per Share | -$1.52 |
| Diluted Earnings Per Share | -$1.52 |
| Basic Average Shares | 121,256,345 |
| Diluted Average Shares | 121,256,345 |
| Assets | $873.02M |
| Current Assets | $446.13M |
| Inventory | $184.48M |
| Other Current Assets | $261.66M |
| Noncurrent Assets | $426.89M |
| Fixed Assets | $130.76M |
| Intangible Assets | $65.97M |
| Other Non-current Assets | $230.16M |
| Liabilities | $443.84M |
| Current Liabilities | $157.01M |
| Accounts Payable | $63.53M |
| Other Current Liabilities | $93.48M |
| Noncurrent Liabilities | $286.83M |
| Equity | $429.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $429.18M |
| Liabilities And Equity | $873.02M |
| Net Cash Flow From Operating Activities | $16.27M |
| Net Cash Flow From Operating Activities, Continuing | $16.27M |
| Net Cash Flow From Investing Activities | -$43.93M |
| Net Cash Flow From Investing Activities, Continuing | -$43.93M |
| Net Cash Flow From Financing Activities | $63.65M |
| Net Cash Flow From Financing Activities, Continuing | $63.65M |
| Net Cash Flow | $35.98M |
| Net Cash Flow, Continuing | $35.98M |
| Comprehensive Income/Loss | -$62.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$62.91M |
| Other Comprehensive Income/Loss | -$41.52M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.19M |